Biologics for RA Archives | Page 2 of 8 | Rheumatoid Arthritis Warrior

21 Tips to Prepare for a Biologic Infusion

How can patients get ready for a Biologic infusion? Doreen asked how to prepare for her upcoming Rituxan infusion. Here are some general tips that might help with any kind of Biologic infusion. As usual, I’ve learned most of these from other patients and from the effective teacher called experience. The orange Rituxan blanket was a gift...Continue reading      18 Comments » Read more

10 Answers to “When Do I Start a Biologic Treatment for Rheumatoid Arthritis?”

Patients ask: How do I know it’s time to start a biologic? This question was recently posted on our Facebook page and it’s one most patients ask at some point. Initiating Biologic therapy is a decision that is obviously made together with your doctor. Here are some factors in this important decision.   One important source of information:...Continue reading      44 Comments » Read more

12 Key Facts about Infusion Reactions with Biologics

An infusion nurse talks about safety with Biologics One practical session at the 2012 American College of Rheumatology (ACR) Scientific Meeting was a short talk on preventing infusion reactions presented by a nurse from Seattle, Christine Elliot. Ms. Elliot has supervised 15,000 rheumatological infusions in over a decade as an infusion nurse. She offered an overview...Continue reading      38 Comments » Read more

Consumer Reports’ Absurd Best Buy Rheumatoid Arthritis Drug List

RESPONSE TO Consumer Reports Health Best Buy Drugs; Evaluating Prescription Drugs Used to Treat the Symptoms of Rheumatoid Arthritis: The Biologics Warrior to Washington: Next week, I’m going to D.C. to make an oral presentation to the “Arthritis Advisory Committee” at a hearing about a new Rheumatoid Arthritis treatment, tofacitinib. I want you to know why...Continue reading      47 Comments » Read more

Are Biosimilars Justice in Competition for Biologics Like Enbrel?

The FDA definition of biosimilars and a pathway to approval Biosimilars are pharmaceuticals that are similar to biologics such as Enbrel and Humira, but not chemically identical as with generic drugs. If the unique molecules used to create a biologic (from living proteins) such as Enbrel are not cloned, but carefully imitated, they are considered “biosimilar.”...Continue reading      13 Comments » Read more
“imaware™
    Advertisement
Would You Like Free Email Updates?
Stay in touch with RA Warrior.
We respect your privacy. Your email address will never be shared.